Cargando…

Hepatocellular Carcinoma in a Patient With Hepatic Steatosis

Hepatocellular carcinoma (HCC) has historically developed in the setting of known risk factors—chronic liver disease from viral hepatitis and cirrhosis. In the absence of a risk factor, the development of HCC was rare. However, the increasing prevalence of nonalcoholic liver disease and nonalcoholic...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, John, Forster, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289280/
https://www.ncbi.nlm.nih.gov/pubmed/32607378
http://dx.doi.org/10.14309/crj.0000000000000378
Descripción
Sumario:Hepatocellular carcinoma (HCC) has historically developed in the setting of known risk factors—chronic liver disease from viral hepatitis and cirrhosis. In the absence of a risk factor, the development of HCC was rare. However, the increasing prevalence of nonalcoholic liver disease and nonalcoholic steatohepatitis, the paradigm is shifting. Currently, no HCC screening guidelines exist for these patients. We report a 30-year-old man with a medical history of treated nonseminomatous germ cell testicular cancer who presented with asymptomatic transaminitis. Subsequent workup was notable for a 1.6-cm liver lesion. The patient underwent a left lobe wedge resection with pathology demonstrating a well-differentiated HCC in a background of hepatic steatosis.